Get Quote

Keryx Biopharmaceuticals (NASDAQ:KERX)

CAPS Game Rating: 1 out of 5

A biopharmaceutical company focused on the acquisition, development and commercialization of medically important, novel pharmaceutical products for the treatment of life-threatening diseases, including diabetes and cancer.

Recs

0
Member Avatar Thelmal (45.14) Submitted: 25/09/2009 09:14:56 : Outperform Start Price: $2.45 KERX Score: +168.84

On the BioTech radar - "merger worthy"

Report this Post Reply

For details about CAPS-UK, and the conditions you agree to be bound by, please see our Terms and Conditions.